These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25540856)

  • 1. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
    Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
    Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study.
    Doustmohamadian S; Serahati S; Barzin M; Keihani S; Azizi F; Hosseinpanah F
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):241-248. PubMed ID: 28139376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study.
    Salehinia F; Abdi H; Hadaegh F; Serahati S; Valizadeh M; Azizi F; Hosseinpanah F
    Diabetes Res Clin Pract; 2018 Oct; 144():17-24. PubMed ID: 30036611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal obesity phenotypes and risk of kidney function decline: Tehran Lipid and Glucose Study.
    Shahali A; Tasdighi E; Barzin M; Mahdavi M; Valizadeh M; Niroomand M; Azizi F; Hosseinpanah F
    Obes Res Clin Pract; 2020; 14(2):168-175. PubMed ID: 32307280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of anthropometric indices in adolescence with the occurrence of the metabolic syndrome in early adulthood: Tehran Lipid and Glucose Study (TLGS).
    Barzin M; Asghari G; Hosseinpanah F; Mirmiran P; Azizi F
    Pediatr Obes; 2013 Jun; 8(3):170-7. PubMed ID: 23042576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study.
    Eshtiaghi R; Keihani S; Hosseinpanah F; Barzin M; Azizi F
    Int J Obes (Lond); 2015 Mar; 39(3):514-9. PubMed ID: 25287753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance status and four-year changes in other cardiometabolic risk factors in West-African adults: the Benin study.
    Sossa C; Delisle H; Agueh V; Makoutodé M; Fayomi B
    Eur J Prev Cardiol; 2013 Dec; 20(6):1042-50. PubMed ID: 22952287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPIC-MORGEN study.
    van der A DL; Nooyens AC; van Duijnhoven FJ; Verschuren MM; Boer JM
    Obesity (Silver Spring); 2014 Feb; 22(2):557-64. PubMed ID: 23595997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
    Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.
    Shab-Bidar S; Hosseini-Esfahani F; Mirmiran P; Hosseinpour-Niazi S; Azizi F
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():98-108. PubMed ID: 23731333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study.
    Popa S; Moţa M; Popa A; Moţa E; Serafinceanu C; Guja C; Catrinoiu D; Hâncu N; Lichiardopol R; Bala C; Popa A; Roman G; Radulian G; Timar R; Mihai B
    J Endocrinol Invest; 2016 Sep; 39(9):1045-53. PubMed ID: 27126310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waist circumference predicts increased cardiometabolic risk in normal weight adolescent males.
    Taylor SA; Hergenroeder AC
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e307-11. PubMed ID: 21649469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolically healthy obesity and the risk for subclinical atherosclerosis.
    Kim TJ; Shin HY; Chang Y; Kang M; Jee J; Choi YH; Ahn HS; Ahn SH; Son HJ; Ryu S
    Atherosclerosis; 2017 Jul; 262():191-197. PubMed ID: 28385392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Index of central obesity as a parameter to replace waist circumference for the definition of metabolic syndrome in predicting cardiovascular disease.
    Luo W; Guo Z; Wu M; Hao C; Zhou Z; Yao X
    J Cardiovasc Med (Hagerstown); 2014 Oct; 15(10):738-44. PubMed ID: 24937473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference.
    Florath I; Brandt S; Weck MN; Moss A; Gottmann P; Rothenbacher D; Wabitsch M; Brenner H
    Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1112-9. PubMed ID: 24932537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemic waist: the point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study.
    Samadi S; Bozorgmanesh M; Khalili D; Momenan A; Sheikholeslami F; Azizi F; Hadaegh F
    Int J Cardiol; 2013 May; 165(2):260-5. PubMed ID: 21924777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal Obesity Phenotypes and Incidence of Thyroid Autoimmunity: A 9-Year Follow-up.
    Amouzegar A; Kazemian E; Abdi H; Gharibzadeh S; Tohidi M; Azizi F
    Endocr Res; 2020 Aug; 45(3):202-209. PubMed ID: 32266835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.